Related references
Note: Only part of the references are listed.Targeting Wistar rat as a model for studying benign, premalignant and malignant lesions of the prostate
Gabriel H. Campolina-Silva et al.
LIFE SCIENCES (2020)
Older Age Is Associated with Decreased Levels of VDR, CYP27B1, and CYP24A1 and Increased Levels of PTH in Human Parathyroid Glands
Yi Jiang et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2020)
Lower serum 25-hydroxyvitamin D is associated with colorectal and breast cancer, but not overall cancer risk: a 20-year cohort study
Kun Zhu et al.
NUTRITION RESEARCH (2019)
Association among plasma 1,25(OH)2D, ratio of 1,25(OH)2D to 25(OH)D, and prostate cancer aggressiveness
Swathi Ramakrishnan et al.
PROSTATE (2019)
Vitamin D protects against oxidative stress, inflammation and hepatorenal damage induced by acute paracetamol toxicity in rat
Mohamed El-Boshy et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
A Collaborative Analysis of Individual Participant Data from 19 Prospective Studies Assesses Circulating Vitamin D and Prostate Cancer Risk
Ruth C. Travis et al.
CANCER RESEARCH (2019)
Vitamin D and testosterone co-ordinately modulate intracellular zinc levels and energy metabolism in prostate cancer cells
Polly Zhang et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2019)
Vitamin D regulates prostate cell metabolism via genomic and non-genomic mitochondrial redox-dependent mechanisms
Chuck C. Blajszczak et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2019)
Vitamin D: Classic and Novel Actions
Angel Gil et al.
ANNALS OF NUTRITION AND METABOLISM (2018)
Regulation of vitamin D metabolizing enzymes in murine renal and extrarenal tissues by dietary phosphate, FGF23, and 1,25(OH)2D3
Larissa Kagi et al.
PLOS ONE (2018)
Reduced vitamin D receptor (VDR) expression and plasma vitamin D levels are associated with aging-related prostate lesions
Gabriel H. Campolina-Silva et al.
PROSTATE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Basal Cells Show Increased Expression of Aromatase and Estrogen Receptor α in Prostate Epithelial Lesions of Male Aging Rats
Monica Morais-Santos et al.
ENDOCRINOLOGY (2018)
Seasonal Variation in Vitamin D in Association with Age, Inflammatory Cytokines, Anthropometric Parameters, and Lifestyle Factors in Older Adults
Leticia Elizondo-Montemayor et al.
MEDIATORS OF INFLAMMATION (2017)
Epidemiology of clinical benign prostatic hyperplasia
Kok Bin Lim
ASIAN JOURNAL OF UROLOGY (2017)
Premalignancy in Prostate Cancer: Rethinking What we Know
Angelo M. De Marzo et al.
CANCER PREVENTION RESEARCH (2016)
Vitamin D attenuates inflammation, fatty infiltration, and cartilage loss in the knee of hyperlipidemic microswine
Vikrant Rai et al.
ARTHRITIS RESEARCH & THERAPY (2016)
Duodenal Expression of 25 Hydroxyvitamin D3-1α-hydroxylase Is Higher in Adolescents Than in Children and Adults
Aneta Gawlik et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Differential expression and regulation of vitamin D hydroxylases and inflammatory genes in prostate stroma and epithelium by 1,25-dihydroxyvitamin D in men with prostate cancer and an in vitro model
Angeline A. Giangreco et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2015)
Changes in Estrogen Receptor ERβ (ESR2) Expression without Changes in the Estradiol Levels in the Prostate of Aging Rats
Monica Morais-Santos et al.
PLOS ONE (2015)
Vitamin D Deficiency Predicts Prostate Biopsy Outcomes
Adam B. Murphy et al.
CLINICAL CANCER RESEARCH (2014)
Increased expression of CYP24A1 correlates with advanced stages of prostate cancer and can cause resistance to vitamin D3-based therapies
Mounia Tannour-Louet et al.
FASEB JOURNAL (2014)
The role of vitamin D in reducing cancer risk and progression
David Feldman et al.
NATURE REVIEWS CANCER (2014)
Vitamin D and Aging
J. Christopher Gallagher
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2013)
Randomized Clinical Trial of Vitamin D3 Doses on Prostatic Vitamin D Metabolite Levels and Ki67 Labeling in Prostate Cancer Patients
Dennis Wagner et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
The Genotype-Tissue Expression (GTEx) project
John Lonsdale et al.
NATURE GENETICS (2013)
Distribution of Vitamin D Receptor and 1α-Hydroxylase in Male Mouse Reproductive Tract
Ahmad Reza Mahmoudi et al.
REPRODUCTIVE SCIENCES (2013)
Dietary Vitamin D3 and 1,25-Dihydroxyvitamin D3 (Calcitriol) Exhibit Equivalent Anticancer Activity in Mouse Xenograft Models of Breast and Prostate Cancer
Srilatha Swami et al.
ENDOCRINOLOGY (2012)
Vitamin D3 Supplementation at 4000 International Units Per Day for One Year Results in a Decrease of Positive Cores at Repeat Biopsy in Subjects with Low-Risk Prostate Cancer under Active Surveillance
David T. Marshall et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Identification of the vitamin D receptor in various cells of the mouse kidney
Yongji Wang et al.
KIDNEY INTERNATIONAL (2012)
Proliferative and Nonproliferative Lesions of the Rat and Mouse Male Reproductive System
Dianne Creasy et al.
TOXICOLOGIC PATHOLOGY (2012)
Risk factors for the onset of prostatic cancer: age, location, and behavioral correlates
Michael Leitzmann et al.
Clinical Epidemiology (2012)
Vitamin D receptor (VDR)-mediated actions of 1α,25(OH)2vitarnin D3: Genomic and non-genomic mechanisms
Mark R. Haussler et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Cytochromes P450 are essential players in the vitamin D signaling system
Inge Schuster
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2011)
Serum 25-Hydroxy Vitamin D and Prostate Cancer Risk in a Large Nested Case-Control Study
Demetrius Albanes et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Serum 25-OH vitamin D levels and risk of developing prostate cancer in older men
Christine M. Barnett et al.
CANCER CAUSES & CONTROL (2010)
Vitamin D receptor and vitamin D metabolizing enzymes are expressed in the human male reproductive tract
Martin Blomberg Jensen et al.
HUMAN REPRODUCTION (2010)
Association between serum 25(OH) D and death from prostate cancer
S. Tretli et al.
BRITISH JOURNAL OF CANCER (2009)
Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: A report from the ASCENT investigators
Tomasz M. Beer et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Vitamin D inhibits the formation of prostatic intraepithelial neoplasia in Nkx3.1;: Pten mutant mice
Whitney Banach-Petrosky et al.
CLINICAL CANCER RESEARCH (2006)
A phase II trial of dexamethasone, vitamin D, and carboplatin in patients with hormone-refractory prostate cancer
Thomas W. Flaig et al.
CANCER (2006)
High dose pulse calcitriol, docetaxel and estramustine for androgen independent prostate cancer: A phase VII study
NM Tiffany et al.
JOURNAL OF UROLOGY (2005)
Regulation of prostaglandin metabolism by calcitriol attenuates growth stimulation in prostate cancer cells
J Moreno et al.
CANCER RESEARCH (2005)
Modulation of CYP27B1 and CYP24 mRNA expression in bone is independent of circulating 1,25(OH)2D3 levels
PH Anderson et al.
BONE (2005)
Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: A longitudinal, nested case-control study in the Nordic countries
P Tuohimaa et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Vitamin D and prostate cancer prevention and treatment
TC Chen et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2003)
Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland)
MH Ahonen et al.
CANCER CAUSES & CONTROL (2000)
Share Paper
